Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2

Background: Benign prostatic hyperplasia (BPH) is the most common urogenital condition in aging males, while inflammation and tissue proliferation constitute the main pathophysiological factors. The adverse effects of currently available BPH medications limit patient compliance. We tested the protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Raafat, Mohamed, Kamel, Amr A., Shehata, Alaa H., Ahmed, Al-Shaimaa F., Bayoumi, Asmaa M. A., Moussa, Rabab A., Abourehab, Mohammed A. S., El-Daly, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880638/
https://www.ncbi.nlm.nih.gov/pubmed/35215244
http://dx.doi.org/10.3390/ph15020130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880638/
https://www.ncbi.nlm.nih.gov/pubmed/35215244
http://dx.doi.org/10.3390/ph15020130

Ejemplares similares